MedPath
HSA Approval

BILAXTEN TABLET 20 MG (PHARMACY ONLY)

SIN17104P

BILAXTEN TABLET 20 MG (PHARMACY ONLY)

BILAXTEN TABLET 20 MG (PHARMACY ONLY)

October 2, 2024

A. MENARINI SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantA. MENARINI SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

R06AX29

Manufacturer Information

A. MENARINI SINGAPORE PTE. LTD.

A. MENARINI MANUFACTURING LOGISTICS AND SERVICES S.r.l.

Active Ingredients

BILASTINE

20.00 mg

Bilastine

Documents

Patient Information Leaflets

Bilaxten Tablet (Pharmacy Only) PIL.pdf

Approved: October 2, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.